Ascending aorta: the use of a physician investigational device exemption.
作者信息
Khoynezhad Ali, Worthington Tiffany, White Rodney
机构信息
MemorialCare Heart and Vascular Institute, Long Beach, CA, USA.
出版信息
Ann Cardiothorac Surg. 2022 Jan;11(1):48-49. doi: 10.21037/acs-2021-taes-32.
Abstract
摘要
相似文献
1
Ascending aorta: the use of a physician investigational device exemption.升主动脉：使用医师研究器械豁免。
Ann Cardiothorac Surg. 2022 Jan;11(1):48-49. doi: 10.21037/acs-2021-taes-32.
2
Feasibility of endovascular repair of ascending aortic pathologies as part of an FDA-approved physician-sponsored investigational device exemption.作为美国食品药品监督管理局（FDA）批准的医生发起的研究性器械豁免的一部分，升主动脉病变血管内修复的可行性。
J Vasc Surg. 2016 Jun;63(6):1483-95. doi: 10.1016/j.jvs.2015.12.029. Epub 2016 Feb 28.
3
Midterm results from a physician-sponsored investigational device exemption clinical trial evaluating physician-modified endovascular grafts for the treatment of juxtarenal aortic aneurysms.一项由医生发起的研究性器械豁免临床试验的中期结果，该试验评估了医生改良的血管内移植物用于治疗近肾主动脉瘤。
J Vasc Surg. 2017 Feb;65(2):294-302. doi: 10.1016/j.jvs.2016.07.123. Epub 2016 Sep 26.
4
Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease.关于ProDisc-L全椎间盘置换术与环形融合术治疗单节段退变性椎间盘疾病的前瞻性、随机、多中心美国食品药品监督管理局研究性器械豁免研究结果。
Spine (Phila Pa 1976). 2007 May 15;32(11):1155-62; discussion 1163. doi: 10.1097/BRS.0b013e318054e377.
5
Cervical disc arthroplasty with PRESTIGE LP disc versus anterior cervical discectomy and fusion: a prospective, multicenter investigational device exemption study.采用PRESTIGE LP椎间盘的颈椎间盘置换术与颈椎前路椎间盘切除融合术：一项前瞻性、多中心研究性器械豁免研究。
J Neurosurg Spine. 2015 Nov;23(5):558-573. doi: 10.3171/2015.1.SPINE14589. Epub 2015 Jul 31.
6
Lumbar disc arthroplasty with Maverick disc versus stand-alone interbody fusion: a prospective, randomized, controlled, multicenter investigational device exemption trial.后路腰椎间盘置换 Maverick 人工椎间盘与单纯后路椎间融合术的前瞻性、随机、对照、多中心临床试验。
Spine (Phila Pa 1976). 2011 Dec 1;36(25):E1600-11. doi: 10.1097/BRS.0b013e318217668f.
7
8
Long-term outcomes of the Ovation Stent Graft System investigational device exemption trial for endovascular abdominal aortic aneurysm repair.用于血管内腹主动脉瘤修复的Ovation覆膜支架系统研究性器械豁免试验的长期结果。
J Vasc Surg. 2020 Nov;72(5):1667-1673.e1. doi: 10.1016/j.jvs.2020.01.066. Epub 2020 Apr 2.
9
A prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part II: evaluation of radiographic outcomes and correlation of surgical technique accuracy with clinical outcomes.一项关于使用CHARITE人工椎间盘进行腰椎全椎间盘置换术与腰椎融合术对比的前瞻性、随机、多中心美国食品药品监督管理局研究器械豁免研究：第二部分：影像学结果评估及手术技术准确性与临床结果的相关性
Spine (Phila Pa 1976). 2005 Jul 15;30(14):1576-83; discussion E388-90. doi: 10.1097/01.brs.0000170561.25636.1c.
10
Prospective study of cervical arthroplasty in 98 patients involved in 1 of 3 separate investigational device exemption studies from a single investigational site with a minimum 2-year follow-up. Clinical article.一项前瞻性研究，共纳入 98 例患者，分别参与了来自单一研究中心的 3 项单独的研究性器械豁免研究，随访时间至少 2 年。临床文章。
J Neurosurg Spine. 2010 Dec;13(6):715-21. doi: 10.3171/2010.5.SPINE09852.
本文引用的文献
1
Endovascular stent grafting for ascending aorta diseases.升主动脉疾病的血管内支架植入术。
J Vasc Surg. 2017 Nov;66(5):1587-1601. doi: 10.1016/j.jvs.2017.07.064. Epub 2017 Aug 19.
2
Feasibility of endovascular repair of ascending aortic pathologies as part of an FDA-approved physician-sponsored investigational device exemption.作为美国食品药品监督管理局（FDA）批准的医生发起的研究性器械豁免的一部分，升主动脉病变血管内修复的可行性。
J Vasc Surg. 2016 Jun;63(6):1483-95. doi: 10.1016/j.jvs.2015.12.029. Epub 2016 Feb 28.
3
Transseptal guidewire stabilization facilitates stent-graft deployment for persistent proximal ascending aortic dissection.经房间隔导丝稳定术有助于持续性升主动脉近端夹层的覆膜支架置入。
J Endovasc Ther. 2000 Dec;7(6):506-12. doi: 10.1177/152660280000700612.
Zotero 插件